Marion Menozzi-Arnaud

Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations

Mercy Mvundura, Collrane Frivold, Anna Janik Osborne et al. · Vaccine · 2021 · 27 citations · Full text

Public Affairs, Health Promotion, Preventive Medicine +16

A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy

Debra Kristensen, Birgitte Giersing, Julian Hickling et al. · Vaccine · 2021 · 16 citations · Full text

Veterinary Medicine, Immunology, Innovation Management +16

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making

Siobhan Botwright, Anna-Léa Kahn, Raymond Hutubessy et al. · Vaccine X · 2020 · 14 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +11

Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities

Tiziana Scarnà, Marion Menozzi-Arnaud, Martin Friede et al. · Expert Opinion on Drug Delivery · 2023 · 12 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Disease Control +17

Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification

Stefano Malvolti, Melissa Ko, Marion Menozzi-Arnaud et al. · Frontiers in Public Health · 2023 · 10 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Diseases +17